Steven M Krausz
CIK 1190636 · last filed 2020-11-19
Steven M Krausz is a corporate insider who has filed 53 SEC Form 4 insider transactions across 7 companies since 2007. Across all open-market trades the lifetime net is −$93.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $215.0M across reported positions. 66 SEC filings were submitted jointly with Irwin Federman.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GWRE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inari Medical, Inc. (NARI) Delisted | 10%+ Owner | 56,173 | $79.97 | $4.49M | $4.27M | 2 | 2020-11-19 |
| BOX | Director | 3,722,856 | $43.45 | $161.76M | -$359.4K | 8 | 2018-06-27 |
| INSP | 10%+ Owner | 750,795 | $68.10 | $51.13M | $0 | 1 | 2018-05-09 |
| IMPERVA INC (IMPV) Delisted | Director | 8,429 | — | — | $914.0K | 12 | 2015-05-07 |
| Intersect ENT, Inc. (XENT) Delisted | 10%+ Owner | 2,985,433 | $28.24 | $84.31M | $0 | 1 | 2015-03-06 |
| GWRE | Director | 12,797 | $162.59 | $2.08M | -$96.91M | 16 | 2013-06-20 |
| Mellanox Technologies, Ltd. (MLNX) Delisted | 10%+ Owner | 1,021 | — | — | -$1.83M | 1 | 2007-09-04 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-15 | — | Notice (144) | −1,615 | -$65.3K | EDGAR |
| 2023-12-01 | INSP | Notice (144) | −504 | -$74.0K | EDGAR |
| 2023-12-01 | INSP | Notice (144) | −1,961 | -$288.0K | EDGAR |
| 2023-05-18 | — | Notice (144) | −8,382 | -$558.2K | EDGAR |
| 2023-05-18 | — | Notice (144) | −8,382 | -$558.2K | EDGAR |
| 2023-05-18 | — | Notice (144) | −6,459 | -$432.8K | EDGAR |
| 2020-11-19 | Inari Medical, Inc. (NARI) Delisted | Mixed | −16,552,168 | -$10.62M | EDGAR |
| 2020-05-27 | Inari Medical, Inc. (NARI) Delisted | Mixed | +62,582,224 | $14.89M | EDGAR |
| 2018-06-27 | BOX | Sell (S) | −14,284 | -$359.4K | EDGAR |
| 2018-06-22 | BOX | Grant (A) | +3,699 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.